Logotype for G5 Entertainment

G5 Entertainment (G5EN) Q3 2026 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for G5 Entertainment

Q3 2026 earnings summary

4 Nov, 2026

Executive summary

  • Q3 revenue was $19.3M, down 19.7% YoY and 4.0% QoQ; net result rose to $2.3M from $1.4M, and EPS to $0.31 from $0.18.

  • Record gross margin of 74.1%, improved EBIT and G5 Store growth supported profitability as established games declined.

Financial highlights

  • Reported EBIT was $1.9M versus $1.3M, with a 9.8% margin versus 5.5%; adjusted EBIT was $2.0M versus $1.4M, with a 10.6% margin versus 5.7%.

  • Q3 gross profit was $14.3M versus $17.1M; gross margin rose to 74.1% from 71.2%.

  • 9M revenue declined 16% to $61.1M; net profit increased to $3.6M from $3.2M, while EBIT was $2.5M versus $2.9M.

  • 9M gross profit was $44.8M versus $50.9M; gross margin rose to 73.3% from 70.3%.

  • EBIT included $0.8M severance, a $0.3M social-security fee release and positive $0.3M FX effects; net capitalization impact was -$0.9M.

Outlook and guidance

  • Workforce optimization was substantially complete; annualized run-rate savings were estimated at $14M, with staffing expected to stabilize near 450 by year-end.

  • The new game remained in soft launch with strong short- and medium-term metrics; further iterations are needed to establish long-term performance and scalability.

  • Priorities included growing G5 Store distribution, direct payments and advertising, alongside financial discipline, cash-flow generation and zero debt.

  • Focus remained on stabilizing and optimizing Sherlock and Hidden City; Jewels and The Secret Society moved to Harvest Mode.

  • UA spend was expected to remain within the previously communicated 18%–22% of revenue range unless the outlook changes.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from G5 Entertainment